Lightnews — Scholar-powered news

Stephen V Liu: Join us for the DC Lung Cancer Conference on October 4th - OncoDaily

2 4

Reposted by Oncology Nurse, MSN, RN

OncoDaily @oncodaily.bsky.social · 26d

Join us for the DC Lung Cancer Conference on October 4th - Stephen V Liu

@stephenvliu.bsky.social

oncodaily.com/voices/steph...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #DCLung25 #LungCancer

Stephen V Liu: Join us for the DC Lung Cancer Conference on October 4th / cancer, DC Lung Cancer Conference, DCLung25, Lung cancer, OncoDaily, Oncology,

Radiotherapy for Pancreatic Cancer: Types, Success Rate, Side Effects And More - OncoDaily

Reposted by Oncology Nurse, MSN, RN

ONCOassist® | The go-to oncology app @oncoassist.bsky.social · 25d

🚨BREAKING: Novocure’s Optune Lua® approved in for unresectable advanced/recurrent #NSCLC.
✅ Can be used with PD-1/PD-L1 inhibitors after platinum chemo
📊 Backed by Phase 3 LUNAR trial, showing significant OS benefit

🔗 Read more: bit.ly/ONCOnews16S-1

1 1 1

Reposted by Oncology Nurse, MSN, RN

OncoDaily @oncodaily.bsky.social · 27d

Radiotherapy for Pancreatic Cancer: Types, Success Rate, Side Effects And More

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Radiotherapy #PancreaticCancer

Radiotherapy for Pancreatic Cancer: Types, Success Rate, Side Effects And More / cancer, OncoDaily, OncoDaily GI, Oncology, Pancreatic Cancer, radiation

Tian Zhang: Finding Better Treatments for Patients with Non-clear Cell Renal Cell Carcinoma - OncoDaily

Reposted by Oncology Nurse, MSN, RN

OncoDaily @oncodaily.bsky.social · 27d

Finding Better Treatments for Patients with Non-clear Cell Renal Cell Carcinoma - Tian Zhang

@tiansterzhangmd.bsky.social

oncodaily.com/voices/tian-...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #RCC #RenalCellCarcinoma

Tian Zhang: Finding Better Treatments for Patients with Non-clear Cell Renal Cell Carcinoma / cancer, kidney cancers, Lisa Henske, OncoDaily, Oncology, Tian

10 Must-Read Posts in Immuno-Oncology This Week - OncoDaily

Reposted by Oncology Nurse, MSN, RN

OncoDaily @oncodaily.bsky.social · 27d

10 Must-Read Posts in Immuno-Oncology This Week

@patrickhwumd.bsky.social

oncodaily.com/societies/im...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #IO #ImmunoOncology

This week’s expert highlights in immuno-oncology spotlight trial updates, novel combinations, and leading voices shaping the future of cancer immunotherapy.

INLEXZO FDA Approval: A Game-Changer in Bladder Cancer Treatment - OncoDaily

Reposted by Oncology Nurse, MSN, RN

OncoDaily @oncodaily.bsky.social · 27d

INLEXZO FDA Approval: A Game-Changer in Bladder Cancer Treatment

oncodaily.com/fda-approval...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #INLEXZO #FDAApproval #BladderCancer

INLEXZO FDA approval brings new hope for BCG-unresponsive bladder cancer, offering a bladder-sparing, high-response alternative to surgery.

New Lung Cancer Considered Episode in Mandarin - IASLC - OncoDaily

Reposted by Oncology Nurse, MSN, RN

OncoDaily @oncodaily.bsky.social · 27d

IASLC - New Lung Cancer Considered Episode in Mandarin

@iaslc.bsky.social

oncodaily.com/voices/lung-...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #LungCancer #LungCancerConsidered #IASLC

New Lung Cancer Considered Episode in Mandarin - IASLC / cancer, Chunxia Su, IASLC, Lung Cancer Considered, Nan Bi, OncoDaily, Oncology, The International

Ruben Mesa: An Amazing Cancer Biology Department Driving Advances Across Advocate Health - OncoDaily

Reposted by Oncology Nurse, MSN, RN

OncoDaily @oncodaily.bsky.social · 27d

An Amazing Cancer Biology Department Driving Advances Across Advocate Health - Ruben Mesa

@rubenmesamd.bsky.social

oncodaily.com/blog/ruben-m...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Ruben Mesa: An Amazing Cancer Biology Department Driving Advances Across Advocate Health / advocate health, Atrium Health, cancer, cancer biology, OncoDaily,

Paolo Tarantino: New Treatments, New Biomarkers, New Hopes for HER2+ Breast Cancer - OncoDaily

2 6

Reposted by Oncology Nurse, MSN, RN

OncoDaily @oncodaily.bsky.social · 27d

New Treatments, New Biomarkers, New Hopes for HER2+ Breast Cancer - Paolo Tarantino

@ptarantinomd.bsky.social

oncodaily.com/voices/paolo...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #BreastCancer

Paolo Tarantino: New Treatments, New Biomarkers, New Hopes for HER2+ Breast Cancer / cancer, Medscape PBCC25, Mohamed Kahila, OncoDaily, Oncology, Paolo

10 Must-Read Posts in Immuno-Oncology This Week - OncoDaily

Reposted by Oncology Nurse, MSN, RN

Lung Cancer Research Foundation @lcrf.org · 26d

Thank you to AstraZeneca for sponsoring the Free to Breathe Chicago Walk on Sunday, October 5th!

LCRF.org/Chicago

#LungCancerAwareness
#FreetoBreatheWalk

1 1

Reposted by Oncology Nurse, MSN, RN

Ishwaria Subbiah MD, MS, FASCO @ishwaria.bsky.social · 26d

1/2: 📢Now out in The Lancet #Oncology📢 Our ASCO/COSA/ECO joint statement and global call to action on #Burnout & #ClinicianWellbeing in Cancer Care from @ascocancer.bsky.social, COSA & @europeancancer.bsky.social🔹Burnout now impacts 𝟱𝟵% of US oncologists from 45% in 2013. Action is 𝗲𝘀𝘀𝗲𝗻𝘁𝗶𝗮𝗹.

1 2 5

Reposted by Oncology Nurse, MSN, RN

International Myeloma Foundation @imfmyeloma.bsky.social · 26d

When you're living with myeloma, the most important thing is to never give up. What inspires you while living with myeloma? Share your story below. Plus, create an easy custom graphic to share at knowmyeloma.org Then show it off on social with the #KnowMyeloma awareness tag!

2 4

Reposted by Oncology Nurse, MSN, RN

International Myeloma Foundation @imfmyeloma.bsky.social · Sep 7

It's Blood Cancer Awareness Month! Myeloma is the 2nd most common blood cancer in the world—but awareness is still low. Repost with #KNOWMyeloma to spread awareness! Learn more about the disease at knowmyeloma.org Thanks to the Binding Site for supporting #BloodCancerAwarenessMonth.

2 4

Reposted by Oncology Nurse, MSN, RN

Lung Cancer Research Foundation @lcrf.org · Sep 7

Thank you to the Rush University Medical Center for sponsoring the Free to Breathe Chicago Walk on Sunday, October 5!

LCRF.org/Chicago
#LungCancerAwareness
#FreetoBreatheWalk

1 1

Reposted by Oncology Nurse, MSN, RN

OncoDaily @oncodaily.bsky.social · Sep 7

10 Must-Read Posts in Immuno-Oncology This Week

@biagioricciutimd.bsky.social @hhorinouchi.bsky.social @drewmoghanaki.bsky.social

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #IO #ImmunoOncology

10 Must-Read Posts in Immuno-Oncology This Week / Alfonso Duenas Gonzalez, Antonio Nuccio, Biagio Ricciuti, cancer, CAR-T therapy advancements, Christina

LIBRETTO-431 East Asia Subgroup Results of First-line Selpercatinib vs Chemotherapy + Pembrolizumab in RET Fusion–Positive NSCLC - OncoDaily

Reposted by Oncology Nurse, MSN, RN

OncoDaily @oncodaily.bsky.social · Sep 7

LIBRETTO-431 East Asia Subgroup Results of First-line Selpercatinib vs Chemotherapy + Pembrolizumab in RET Fusion–Positive NSCLC

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #LIBRETTO431 #Selpercatinib #Pembrolizumab #NSCLC #LungCancer #IO

LIBRETTO-431 East Asia Subgroup Results of First-line Selpercatinib vs Chemotherapy + Pembrolizumab in RET Fusion–Positive NSCLC / cancer, LIBRETTO-431,

Can AI Cure Cancer? What Patients Should Know - OncoDaily

Reposted by Oncology Nurse, MSN, RN

OncoDaily @oncodaily.bsky.social · Sep 7

Can AI Cure Cancer? What Patients Should Know

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #AI #ArtificialIntelligence #CancerDetection

Can AI cure cancer? Learn how artificial intelligence improves early diagnosis, supports doctors, and helps patients get faster, accurate care.

Zongertinib (Hernexeos) Updates 2025: Uses in Cancer, Side Effects, Dosage, Expectations, and More - OncoDaily

Reposted by Oncology Nurse, MSN, RN

OncoDaily @oncodaily.bsky.social · Sep 7

Zongertinib (Hernexeos) Updates 2025: Uses in Cancer, Side Effects, Dosage, Expectations, and More

oncodaily.com/drugs/zonger...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Zongertinib #Hernexeos #LungCancer #NSCLC

Zongertinib is a selective TKI designed to target cancers driven by HER2 mutations. Learn more about its side effects, dosage, expectations.

Herbert Loong: Grateful for the Journey with ASCO International Affairs Committee - OncoDaily

Reposted by Oncology Nurse, MSN, RN

OncoDaily @oncodaily.bsky.social · Sep 7

Grateful for the Journey with ASCO International Affairs Committee - Herbert Loong

@herbloongmd.bsky.social @ascocancer.bsky.social

oncodaily.com/voices/362254

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ASCO

Herbert Loong: Grateful for the Journey with ASCO International Affairs Committee / American Society of Clinical Oncology, ASCO, cancer, Headlines, Herbert

MD Anderson and Phoenix SENOLYTIX in Cross-Licensing Deal to Advance Cell and Gene Therapies - OncoDaily

Reposted by Oncology Nurse, MSN, RN

OncoDaily @oncodaily.bsky.social · Sep 7

MD Anderson and Phoenix SENOLYTIX in Cross-Licensing Deal to Advance Cell and Gene Therapies

@mdanderson.bsky.social

oncodaily.com/insight/md-a...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #MDAnderson #PhoenixSENOLYTIX #CellTherapy #GeneTherapy

MD Anderson and Phoenix SENOLYTIX in Cross-Licensing Deal to Advance Cell and Gene Therapies / cancer, CaspaCIDe, Dual Switch, GoCAR-T, GoDCVaX, GoTCR, Katy

WCLC 2025 Highlights: FLAURA2 trial - OncoDaily

Reposted by Oncology Nurse, MSN, RN

OncoDaily @oncodaily.bsky.social · Sep 7

WCLC 2025 Highlights: FLAURA2 trial

@iaslc.bsky.social

oncodaily.com/insight/wclc...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #WCLC #WCLC25 #FLAURA2 #IASLC

WCLC 2025 Highlights: FLAURA2 trial / Alessio Cortellini, Alfredo Addeo, Amit Kulkarni, Amol Akhade, Ana I. Velázquez Mañana, Antonio Calles, Bartomeu

Childhood Cancer in Pakistan: Factors Driving Treatment Abandonment at a Tertiary Center - OncoDaily

Reposted by Oncology Nurse, MSN, RN

OncoDaily @oncodaily.bsky.social · Sep 7

Childhood Cancer in Pakistan: Factors Driving Treatment Abandonment at a Tertiary Center

oncodaily.com/new-paper-al...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ChildhoodCancer #Pakistan #TertiaryCenter

Childhood Cancer in Pakistan: Factors Driving Treatment Abandonment at a Tertiary Center / cancer, Childhood Cancer, OncoDaily, Oncology, Pakistan, pediatric

Jarushka Naidoo: David O Reilly Wins IASLC Adi Gazdar Grant - OncoDaily

Reposted by Oncology Nurse, MSN, RN

OncoDaily @oncodaily.bsky.social · Sep 7

David O Reilly Wins IASLC Adi Gazdar Grant - Jarushka Naidoo

@drjnaidoo.bsky.social @iaslc.bsky.social

oncodaily.com/career/jarus...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #IASLC

Jarushka Naidoo: David O Reilly Wins IASLC Adi Gazdar Grant / Beaumont RCSI Cancer Centre, cancer, David O Reilly, IASLC, Jarushka Naidoo, liquid biopsy,